# Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium

> **NCT05273827** · — · COMPLETED · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 81 (actual)

## Conditions studied

- Immunotherapy
- Analgesia
- NSCLC
- Delirium

## Interventions

- **DRUG:** neoadjuvant immunotherapy
- **DRUG:** Neoadjuvant chemotherapy

## Key facts

- **NCT ID:** NCT05273827
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-22
- **Primary completion:** 2023-12-20
- **Final completion:** 2024-01-02
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2024-01-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05273827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05273827, "Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05273827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*